Albert DeNittis, M.D., M.S.

Education and Background

Dr. DeNittis comes to us from Main Line Health. He served for 21 years as chief of Radiation Oncology at Lankenau Medical Center.

He received his medical doctorate from Rutgers/Robert Johnson Medical School. This was preceded by a master’s degree in Developmental and Molecular Biology also at Rutgers. He then completed his residency at the University of Pennsylvania in Radiation Oncology.

During his tenure at Mainline Health, Dr. DeNittis has treated thousands of patients. He specializes in numerous radiation techniques including intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), high dose rate (HDR) brachytherapy, as well as stereotactic radiosurgery (SRS) used in the treatment of brain tumors.

At Main Line Health he was part of a multidisciplinary team treating lung cancer patients. This team was part of a lung tumor nodule program detecting early-stage lung cancers and treating them using SBRT. He was also part of the national accreditation program for rectal cancer (NAPRC) which is was awarded a Designation of Excellence to treat these patients.

Dr. DeNittis was also a full clinical professor, serving as principal investigator for the clinical research program of Mainline Health.

In his free time Dr. DeNittis loves spending time with family. He has a love for travel, the Philadelphia Eagles, and spending time at his house at Longport, New Jersey when able.

Specialties

Prostate, lung, brain, gastrointestinal cancers with an emphasis on rectum, and all gynecologic cancers

Certifications, Memberships, Accomplishments

Through the National Cancer Institute (NCI), he served on many national committees as well as a special task force on anal and rectal cancer. He has numerous publications and has presented at over 100 national meetings. Dr. DeNittis has also developed new techniques and published a clinical trial registered through the NCI to treat prostate cancer patients in five days.

Dr. DeNittis has been named a Philadelphia Top Doctor from 2012 to present.

Albert DeNittis, M.D., M.S.

Education and Background

Dr. DeNittis comes to us from Main Line Health. He served for 21 years as chief of Radiation Oncology at Lankenau Medical Center.

He received his medical doctorate from Rutgers/Robert Johnson Medical School. This was preceded by a master’s degree in Developmental and Molecular Biology also at Rutgers. He then completed his residency at the University of Pennsylvania in Radiation Oncology.

During his tenure at Mainline Health, Dr. DeNittis has treated thousands of patients. He specializes in numerous radiation techniques including intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), high dose rate (HDR) brachytherapy, as well as stereotactic radiosurgery (SRS) used in the treatment of brain tumors.

At Main Line Health he was part of a multidisciplinary team treating lung cancer patients. This team was part of a lung tumor nodule program detecting early-stage lung cancers and treating them using SBRT. He was also part of the national accreditation program for rectal cancer (NAPRC) which is was awarded a Designation of Excellence to treat these patients.

Dr. DeNittis was also a full clinical professor, serving as principal investigator for the clinical research program of Mainline Health.

In his free time Dr. DeNittis loves spending time with family. He has a love for travel, the Philadelphia Eagles, and spending time at his house at Longport, New Jersey when able.

Specialties

Prostate, lung, brain, gastrointestinal cancers with an emphasis on rectum, and all gynecologic cancers

Certifications, Memberships, Accomplishments

Through the National Cancer Institute (NCI), he served on many national committees as well as a special task force on anal and rectal cancer. He has numerous publications and has presented at over 100 national meetings. Dr. DeNittis has also developed new techniques and published a clinical trial registered through the NCI to treat prostate cancer patients in five days.

Dr. DeNittis has been named a Philadelphia Top Doctor from 2012 to present.

Albert DeNittis, M.D., M.S.

Education and Background

Dr. DeNittis comes to us from Main Line Health. He served for 21 years as chief of Radiation Oncology at Lankenau Medical Center.

He received his medical doctorate from Rutgers/Robert Johnson Medical School. This was preceded by a master’s degree in Developmental and Molecular Biology also at Rutgers. He then completed his residency at the University of Pennsylvania in Radiation Oncology.

During his tenure at Mainline Health, Dr. DeNittis has treated thousands of patients. He specializes in numerous radiation techniques including intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), high dose rate (HDR) brachytherapy, as well as stereotactic radiosurgery (SRS) used in the treatment of brain tumors.

At Main Line Health he was part of a multidisciplinary team treating lung cancer patients. This team was part of a lung tumor nodule program detecting early-stage lung cancers and treating them using SBRT. He was also part of the national accreditation program for rectal cancer (NAPRC) which is was awarded a Designation of Excellence to treat these patients.

Dr. DeNittis was also a full clinical professor, serving as principal investigator for the clinical research program of Mainline Health.

In his free time Dr. DeNittis loves spending time with family. He has a love for travel, the Philadelphia Eagles, and spending time at his house at Longport, New Jersey when able.

Specialties

Prostate, lung, brain, gastrointestinal cancers with an emphasis on rectum, and all gynecologic cancers

Certifications, Memberships, Accomplishments

Through the National Cancer Institute (NCI), he served on many national committees as well as a special task force on anal and rectal cancer. He has numerous publications and has presented at over 100 national meetings. Dr. DeNittis has also developed new techniques and published a clinical trial registered through the NCI to treat prostate cancer patients in five days.

Dr. DeNittis has been named a Philadelphia Top Doctor from 2012 to present.